Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Jeffrey

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Cellular Neuroscience|January 11, 2020
3D Ultrastructure of the Cochlear Outer Hair Cell Lateral Wall Revealed By Electron TomographyWilliam Jeffrey Triffo, Hildur Palsdottir, Junha Song, et al.
Annals of Hematology|August 12, 2003
Post-transplant interleukin-2 in patients with low-grade lymphoid neoplasms previously treated with fludarabine is limited by hematologic toxicityJamie K Waselenko, Ann Burrows, Douglas A Nelson, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 21, 2019
Ablative brain surgery: an overviewAndrea Franzini, Shayan Moosa, Domenico Servello, et al.
Journal of Community Health|August 10, 2019
The Effect of Place of Service on Diabetic Screening Adherence in the Homeless PopulationMary Katherine Wainwright, Melinda Earle, Kari Kosog, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2009
A phase I study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and maintenance gefitinib for patients with stage III non-small cell lung cancerBrian Center, William Jeffrey Petty, Diandra Ayala, et al.
Neurosurgery|January 20, 2021
Enhanced Recovery After Surgery Pathway for Single-Level Minimally Invasive Transforaminal Lumbar Interbody Fusion Decreases Length of Stay and Opioid ConsumptionMena G Kerolus, Ketan Yerneni, Christopher D Witiw, et al.
International Orthopaedics|June 5, 2014
Olecranon fractures: factors influencing re-operationMark Christopher Snoddy, Maximilian Frank Lang, Thomas J An, et al.
Frontiers in Oncology|May 3, 2021
Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle AspiratesJing Su, Lynn S Huang, Ryan Barnard, et al.
American Journal of Hematology|January 21, 2018
Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label studyCarlo Gambacorti-Passerini, Sergey Orlov, Li Zhang, et al.
Journal of Neuro-Oncology|May 25, 2026
Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patientsSarah E Glynn, Ralph D'Agostino, Claire M Lanier, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Cellular Neuroscience|January 11, 2020
3D Ultrastructure of the Cochlear Outer Hair Cell Lateral Wall Revealed By Electron TomographyWilliam Jeffrey Triffo, Hildur Palsdottir, Junha Song, et al.
Annals of Hematology|August 12, 2003
Post-transplant interleukin-2 in patients with low-grade lymphoid neoplasms previously treated with fludarabine is limited by hematologic toxicityJamie K Waselenko, Ann Burrows, Douglas A Nelson, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 21, 2019
Ablative brain surgery: an overviewAndrea Franzini, Shayan Moosa, Domenico Servello, et al.
Journal of Community Health|August 10, 2019
The Effect of Place of Service on Diabetic Screening Adherence in the Homeless PopulationMary Katherine Wainwright, Melinda Earle, Kari Kosog, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2009
A phase I study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and maintenance gefitinib for patients with stage III non-small cell lung cancerBrian Center, William Jeffrey Petty, Diandra Ayala, et al.
Neurosurgery|January 20, 2021
Enhanced Recovery After Surgery Pathway for Single-Level Minimally Invasive Transforaminal Lumbar Interbody Fusion Decreases Length of Stay and Opioid ConsumptionMena G Kerolus, Ketan Yerneni, Christopher D Witiw, et al.
International Orthopaedics|June 5, 2014
Olecranon fractures: factors influencing re-operationMark Christopher Snoddy, Maximilian Frank Lang, Thomas J An, et al.
Frontiers in Oncology|May 3, 2021
Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle AspiratesJing Su, Lynn S Huang, Ryan Barnard, et al.
American Journal of Hematology|January 21, 2018
Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label studyCarlo Gambacorti-Passerini, Sergey Orlov, Li Zhang, et al.
Journal of Neuro-Oncology|May 25, 2026
Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patientsSarah E Glynn, Ralph D'Agostino, Claire M Lanier, et al.
Pageof 3